Portfolio manager Dan LeVan heads Trivalent, a Boston-based international equity boutique that specializes in non-US developed- and emerging-markets strategies under Victory Capital's umbrella.

After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the ...

The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in securities of small- to mid-capitalization companies.

The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the ...

The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming ...

ABSTRACT: In this paper, the commercial BSC16 trivalent chromium hard chromium plating solution was used as the base solution, nickel sulfate or nickel sulfonic acid was added, and the chromium-nickel ...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) had been scheduled to meet to discuss the strains ...

The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting ...

The U.S. FDA issues flu vaccine strain recommendations for 2025-2026 on its own without advisory input. Read more here.

The FDA recommends trivalent flu vaccines for the 2025-2026 season, protecting against 2 influenza A strains and 1 influenza B strain.

I. Updates on 2025-2026 northern hemisphere influenza vaccine strains To maintain vaccine efficacy, WHO regularly updates ...

The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.